{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,6]],"date-time":"2026-02-06T02:57:07Z","timestamp":1770346627614,"version":"3.49.0"},"reference-count":26,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,9,30]],"date-time":"2024-09-30T00:00:00Z","timestamp":1727654400000},"content-version":"vor","delay-in-days":60,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100005564","name":"Gilead Sciences","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100005564","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004334","name":"Organon Inc","doi-asserted-by":"publisher","award":["55906"],"award-info":[{"award-number":["55906"]}],"id":[{"id":"10.13039\/100004334","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.com.au","clinicalkey.es","ajog.org","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Journal of Obstetrics and Gynecology"],"published-print":{"date-parts":[[2024,8]]},"DOI":"10.1016\/j.ajog.2024.03.001","type":"journal-article","created":{"date-parts":[[2024,3,7]],"date-time":"2024-03-07T08:18:43Z","timestamp":1709799523000},"page":"242.e1-242.e9","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["A randomized trial of double vs single-dose etonogestrel implant to overcome the interaction with efavirenz-based antiretroviral therapy"],"prefix":"10.1016","volume":"231","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3631-3765","authenticated-orcid":false,"given":"Catherine A.","family":"Chappell","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohammed","family":"Lamorde","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shadia","family":"Nakalema","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Isabella","family":"Kyohairwe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pauline","family":"Byakika-Kibwika","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Leslie A.","family":"Meyn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michelle M.","family":"Pham","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kimberly K.","family":"Scarsi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"Suppl 2","key":"10.1016\/j.ajog.2024.03.001_bib2","first-page":"ii54","article-title":"From effectiveness to impact: contraception as an HIV prevention intervention","volume":"84","author":"Wilcher","year":"2008","journal-title":"Sex\u00a0Transm Infect"},{"key":"10.1016\/j.ajog.2024.03.001_bib3","doi-asserted-by":"crossref","first-page":"969","DOI":"10.2165\/11591290-000000000-00000","article-title":"Efficacy and safety of long-acting reversible contraception","volume":"71","author":"Stoddard","year":"2011","journal-title":"Drugs"},{"key":"10.1016\/j.ajog.2024.03.001_bib4","doi-asserted-by":"crossref","first-page":"17","DOI":"10.9745\/GHSP-D-17-00396","article-title":"Liftoff: the blossoming of contraceptive implant use in Africa","volume":"6","author":"Jacobstein","year":"2018","journal-title":"Glob Health Sci Pract"},{"key":"10.1016\/j.ajog.2024.03.001_bib5","doi-asserted-by":"crossref","first-page":"205","DOI":"10.9745\/GHSP-D-19-00383","article-title":"Scaling up access to implants: a summative evaluation of the implants access program","volume":"8","author":"Braun","year":"2020","journal-title":"Glob Health Sci Pract"},{"key":"10.1016\/j.ajog.2024.03.001_bib6","doi-asserted-by":"crossref","first-page":"2491","DOI":"10.1093\/humrep\/dew222","article-title":"Extended use up to 5 years of the etonogestrel-releasing subdermal contraceptive implant: comparison to levonorgestrel-releasing subdermal implant","volume":"31","author":"Ali","year":"2016","journal-title":"Hum Reprod"},{"key":"10.1016\/j.ajog.2024.03.001_bib7","doi-asserted-by":"crossref","first-page":"586.e1","DOI":"10.1016\/j.ajog.2017.01.036","article-title":"Prolonged use of the etonogestrel implant and levonorgestrel intrauterine device: 2 years beyond Food and Drug Administration-approved duration","volume":"216","author":"McNicholas","year":"2017","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ajog.2024.03.001_bib8","doi-asserted-by":"crossref","first-page":"e474","DOI":"10.1016\/S2352-3018(15)00184-8","article-title":"Pregnancy rates in HIV-positive women using contraceptives and efavirenz-based or nevirapine-based antiretroviral therapy in Kenya: a retrospective cohort study","volume":"2","author":"Patel","year":"2015","journal-title":"Lancet HIV"},{"key":"10.1016\/j.ajog.2024.03.001_bib9","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1093\/cid\/civ1001","article-title":"Unintended pregnancies observed with combined use of the levonorgestrel contraceptive implant and efavirenz-based antiretroviral therapy: a three-arm pharmacokinetic evaluation over 48 weeks","volume":"62","author":"Scarsi","year":"2016","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ajog.2024.03.001_bib10","doi-asserted-by":"crossref","first-page":"1995","DOI":"10.1097\/QAD.0000000000002308","article-title":"A\u00a0pharmacokinetic and pharmacogenetic evaluation of contraceptive implants and antiretroviral therapy among women in Kenya and Uganda","volume":"33","author":"Patel","year":"2019","journal-title":"AIDS"},{"key":"10.1016\/j.ajog.2024.03.001_bib11","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1097\/QAI.0000000000000189","article-title":"Effect of antiretroviral therapy including lopinavir\/ritonavir or efavirenz on etonogestrel-releasing implant pharmacokinetics in HIV-positive women","volume":"66","author":"Vieira","year":"2014","journal-title":"J\u00a0Acquir Immune Defic Syndr"},{"key":"10.1016\/j.ajog.2024.03.001_bib12","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.contraception.2021.08.006","article-title":"Interactions between etonogestrel-releasing contraceptive implant and 3 antiretroviral regimens","volume":"105","author":"Kreitchmann","year":"2022","journal-title":"Contraception"},{"key":"10.1016\/j.ajog.2024.03.001_bib13","doi-asserted-by":"crossref","first-page":"1965","DOI":"10.1097\/QAD.0000000000001591","article-title":"Efavirenz decreases etonogestrel exposure: a pharmacokinetic evaluation of implantable contraception with antiretroviral therapy","volume":"31","author":"Chappell","year":"2017","journal-title":"AIDS"},{"key":"10.1016\/j.ajog.2024.03.001_bib14","unstructured":"WHO laboratory manual for the Examination and processing of human semen. 5th ed. Published online 2010. https:\/\/www.who.int\/publications\/i\/item\/9789240030787. Accessed March 24, 2024."},{"key":"10.1016\/j.ajog.2024.03.001_bib15","unstructured":"Rsc D. Division of AIDS (DAIDS) table for grading the severity of adult and pediatric adverse events. Published online\u00a02017. https:\/\/rsc.niaid.nih.gov\/clinical-research-sites\/daids-adverse-event-grading-tables. Accessed March 24, 2024"},{"key":"10.1016\/j.ajog.2024.03.001_bib16","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1016\/j.contraception.2018.12.010","article-title":"A\u00a0sensitive and robust UPLC-MS\/MS method for quantitation of estrogens and progestogens in human serum","volume":"99","author":"Zhang","year":"2019","journal-title":"Contraception"},{"key":"10.1016\/j.ajog.2024.03.001_bib17","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1093\/jac\/dki308","article-title":"Intracellular and plasma pharmacokinetics of efavirenz in HIV-infected individuals","volume":"56","author":"Almond","year":"2005","journal-title":"J\u00a0Antimicrob Chemother"},{"key":"10.1016\/j.ajog.2024.03.001_bib18","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1177\/0163278703261198","article-title":"Sample-size requirements for comparisons of two groups on repeated observations of a binary outcome","volume":"27","author":"Leon","year":"2004","journal-title":"Eval Health Prof"},{"key":"10.1016\/j.ajog.2024.03.001_bib19","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1016\/S0002-9378(97)70520-9","article-title":"Single luteal phase serum progesterone assay as an indicator of ovulation","volume":"176","author":"Israel","year":"1997","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ajog.2024.03.001_bib20","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1016\/S0015-0282(98)00015-6","article-title":"Ovarian function during the use of a single contraceptive implant: Implanon compared with Norplant","volume":"69","author":"M\u00e4k\u00e4r\u00e4inen","year":"1998","journal-title":"Fertil Steril"},{"key":"10.1016\/j.ajog.2024.03.001_bib21","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1067\/mcp.2003.22","article-title":"Population pharmacokinetics and effects of efavirenz in patients with human immunodeficiency virus infection","volume":"73","author":"Csajka","year":"2003","journal-title":"Clin Pharmacol Ther"},{"key":"10.1016\/j.ajog.2024.03.001_bib22","doi-asserted-by":"crossref","DOI":"10.1016\/j.contraception.2023.109975","article-title":"Effect of double-dose levonorgestrel subdermal implant in women taking efavirenz-based antiretroviral therapy: the DoubLNG pharmacokinetic study","volume":"122","author":"Cirrincione","year":"2023","journal-title":"Contraception"},{"key":"10.1016\/j.ajog.2024.03.001_bib23","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.contraception.2016.03.006","article-title":"Impact of obesity on the pharmacokinetics of levonorgestrel-based emergency contraception: single and double dosing","volume":"94","author":"Edelman","year":"2016","journal-title":"Contraception"},{"key":"10.1016\/j.ajog.2024.03.001_bib24","doi-asserted-by":"crossref","DOI":"10.1016\/j.contraception.2023.109951","article-title":"Pharmacokinetics of dose-adjusted levonorgestrel emergency contraception combined with efavirenz-based antiretroviral therapy or rifampicin-containing tuberculosis regimens","volume":"121","author":"Scarsi","year":"2023","journal-title":"Contraception"},{"key":"10.1016\/j.ajog.2024.03.001_bib25","article-title":"Contraceptive implant use duration is not associated with breakthrough pregnancy among women living with HIV and using efavirenz: a retrospective, longitudinal analysis","volume":"25","author":"Stalter","year":"2022","journal-title":"J\u00a0Int AIDS Soc"},{"key":"10.1016\/j.ajog.2024.03.001_bib27","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1016\/0010-7824(91)90030-J","article-title":"Clinical trial with 3-keto-desogestrel subdermal implants","volume":"44","author":"D\u00edaz","year":"1991","journal-title":"Contraception"},{"key":"10.1016\/j.ajog.2024.03.001_bib28","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.1093\/jac\/dkx515","article-title":"Physiologically based pharmacokinetic modelling\u00a0prediction of the effects of dose adjustment in\u00a0drug-drug interactions between levonorgestrel\u00a0contraceptive implants and efavirenz-based ART","volume":"73","author":"Roberts","year":"2018","journal-title":"J\u00a0Antimicrob Chemother"}],"container-title":["American Journal of Obstetrics and Gynecology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002937824004241?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002937824004241?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,10,8]],"date-time":"2024-10-08T16:38:51Z","timestamp":1728405531000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002937824004241"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8]]},"references-count":26,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2024,8]]}},"alternative-id":["S0002937824004241"],"URL":"https:\/\/doi.org\/10.1016\/j.ajog.2024.03.001","relation":{},"ISSN":["0002-9378"],"issn-type":[{"value":"0002-9378","type":"print"}],"subject":[],"published":{"date-parts":[[2024,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A randomized trial of double vs single-dose etonogestrel implant to overcome the interaction with efavirenz-based antiretroviral therapy","name":"articletitle","label":"Article Title"},{"value":"American Journal of Obstetrics and Gynecology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ajog.2024.03.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}